Roman Grunt – CEO, Quinta Analytica, Czech Republic
Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to…
sdružení smluvních výzkumných organizací (CRO) v České republice,
Last updated: 13.02.2014
Address: Nám. Hrdinů 6/1034 140 00 Prague 4 ,Czech Republic
Tel: + 420 241 410 196
Company description
ACRO-CZ is a professional association of Contract Research Organizations (CRO) in the Czech Republic, which focus on clinical research and the development of pharmaceuticals. The association was founded in 2005 and it is a member of the European federation of CRO’s.
Products and services
The main goal of the association is to represent CRO’s in conceptual negotiations with state authorities and institutions, as well as internationally, to actively participate in discussions regarding the creation of legal and ethical norms in the area of clinical research and to create conditions for further education of its members, as well as to develop cooperation in the area of clinical evaluation of pharmaceuticals.
Related
Report / New Czech Republic Pharma Report April 2020 Out Now
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Czech Republic is available for…
CEE / Medtech's Enduring Importance for Czech Healthcare
Key stakeholders within the Czech medtech industry highlight how medical devices can improve efficiency and quality…
Roman Samiec – General Manager, Thuasne Czech Republic
Roman Samiec, general manager of Thuasne Czech Republic, introduces the company as a key competitor in the medical…
Jiří Pavlíček – CEO, Aspironix & Chairman, CzechMed and Miroslav…
Miroslav Palát, president of CzechMed, the medical device association in the Czech Republic, and Jiří…
Pavla Nevolová – Country Head, EastHORN Czech Republic
Pavla Nevolová, country head of EastHORN in the Czech Republic, shares the historical roots of the now…
Clinical Trials / Finding the Niches in the Czech Republic
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning…
Pharma Faces / Jiří Žák, Chairman of FARMAK, Czech Republic
In 1996 Jiří Žák, chairman & current CEO of FARMAK, borrowed half a billion Czech crowns to take over a…
Company Spotlight / STADA Czech Republic
As one of the few pharma companies in the Czech Republic to offer products across the whole healthcare spectrum,…
Roman Dusil – General Manager, Pierre Fabre Laboratories Czech Republic…
Roman Dusil, GM of Pierre Fabre Laboratories in the Czech Republic and Slovakia, shares how the Czech affiliate is…
Market Access / A New Era in the Czech Republic?
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most…
Orphan Drugs / Building the Regulatory Framework in the Czech Republic
A cross-industry push for better and broader access to innovative treatments is underway in the Czech Republic.…
